-
Posted by
Two Blokes Jul 17 -
Filed in
Stock
-
4 views
I rate IDEXX Laboratories a buy, driven by a lasting surge in pet ownership and IDXX's leadership in veterinary diagnostics. New platforms like inVue Dx and Cancer Dx provide additional growth drivers, with strong early adoption and potential for margin expansion. IDXX's recurring revenue model, robust retention, and expanding high-margin consumables base support sustained revenue and earnings growth.
